A prospective, single-arm study on the use of the da Vinci® Table Motion with the Trumpf TS7000dV operating table
The da Vinci® Table Motion (dVTM) comprises a combination of a unique operating table (Trumpf Medical™ TruSystem® 7000dV) capable of isocenter motion connected wirelessly with the da Vinci Xi® robotic platform, thereby enabling patients to be repositioned without removal of instruments and or undocking the robot.
Materials and methods
Between May 2015 to October 2015, the first human use of dVTM was carried out in this prospective, single-arm, post-market study in the EU, for which 40 patients from general surgery (GS), urology (U), or gynecology (G) were enrolled prospectively. Primary endpoints of the study were dVTM feasibility, efficacy, and safety.
Surgeons from the three specialties obtained targeting success and the required table positioning in all cases. Table movement/repositioning was necessary to gain exposure of the operating field in 106/116 table moves (91.3%), change target in 2/116 table moves (1.7%), achieve hemodynamic relief in 4/116 table moves (3.5%), and improve external access for tumor removal in 4/116 table moves (3.5%). There was a significantly higher use of tilt and tilt plus Trendelenburg in GS group (GS vs. U p = 0.055 and GS vs. G p = 0.054). There were no dVTM safety-related or adverse events.
The dVTM with TruSystem 7000dV operating table in wireless communication with the da Vinci Xi is a perfectly safe and effective synergistic combination, which allows repositioning of the patient whenever needed without imposing any delay in the execution of the operation. Moreover, it is helpful in avoiding extreme positions and enables the anesthesiologist to provide immediate and effective hemodynamic relief to the patient when needed.
Keywordsda Vinci Xi Robotic surgery da Vinci Table Motion (dVTM)
Study supported by Intuitive Surgical, Inc.
Study conception and design: Prof. ML, Dott. PM, Prof. ST, Dott. CV, Dott. PA, Prof. SC, Dott. BP, Dott. FF, Dott. CM, Dott. ZC, Dott. BL, Prof. CA, and Dott. MF; Acquisition of data: Prof. ML, Prof. ST, Dott. CV, Dott. PA, Prof. SC, Dott. BP, Dott. FF, Dott. CM, Dott. ZC, and Dott. MF; Analysis and interpretation of data: Prof. ML, Dott. PM, Prof. ST, Dott. ZC, Dott. BL, Prof. CA, and Dott. MF; Drafting of manuscript: Prof. ML, Dott. PM, Prof. ST, Dott. BL, and Prof. CA; Critical revision of manuscript: Prof. ML, Prof. ST, Prof. CA, and Dott. MF.
Compliance with ethical standards
Prof. Morelli Luca, Dr. Palmeri Matteo, Prof. Simoncini Tommaso, Dr. Cela Vito, Dr. Perutelli Alessandra, Prof. Selli Cesare, Dr. Buccianti Piero, Dr. Francesca Francesco, Dr. Cecchi Massimo, Dr. Zirafa Cristina, Dr. Bastiani Luca, Prof. Cuschieri Alfred, and Dr. Melfi Franca have no conflicts of interest or financial ties to disclose.
- 3.Bouquet de Joliniere J, Librino A, Dubuisson JB, Khomsi F, Ben Ali N, Fadhlaoui A, Ayoubi JM, Feki A (2016) Robotic surgery in gynecology. Front Surg 2(3):26Google Scholar
- 15.Morelli L, Guadagni S, Di Franco G, Palmeri M, Caprili G, D’Isidoro C, Cobuccio L, Marciano E, Mosca F (2017) Use of the new da Vinci Xi® during robotic rectal resection for cancer: a pilot matched-case comparison with the da Vinci Si®. Int J Med Robot. https://doi.org/10.1002/rcs.1728 PubMedGoogle Scholar
- 16.Giannini A, Russo E, Mannella P, Palla G, Pisaneschi S, Cecchi E, Maremmani M, Morelli L, Perutelli A, Cela V, Melfi F, Simoncini T (2016) First series of total robotic hysterectomy (TRH) using new integrated table motion for the da Vinci Xi: feasibility, safety and efficacy. Surg Endosc. https://doi.org/10.1007/s00464-016-5331-x Google Scholar